348 related articles for article (PubMed ID: 33710501)
21. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.
Sacks FM; Dzau VJ
Am J Med; 1986 Feb; 80(2A):71-81. PubMed ID: 3080883
[TBL] [Abstract][Full Text] [Related]
22. Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
Farnier M; Zeller M; Masson D; Cottin Y
Arch Cardiovasc Dis; 2021 Feb; 114(2):132-139. PubMed ID: 33546998
[TBL] [Abstract][Full Text] [Related]
23. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system.
Eisenberg S
Klin Wochenschr; 1983 Feb; 61(3):119-32. PubMed ID: 6843039
[TBL] [Abstract][Full Text] [Related]
24. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
25. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
Chapman MJ; Ginsberg HN; Amarenco P; Andreotti F; Borén J; Catapano AL; Descamps OS; Fisher E; Kovanen PT; Kuivenhoven JA; Lesnik P; Masana L; Nordestgaard BG; Ray KK; Reiner Z; Taskinen MR; Tokgözoglu L; Tybjærg-Hansen A; Watts GF;
Eur Heart J; 2011 Jun; 32(11):1345-61. PubMed ID: 21531743
[TBL] [Abstract][Full Text] [Related]
26. Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.
Packard CJ; Pirillo A; Tsimikas S; Ference BA; Catapano AL
Cardiovasc Res; 2024 Feb; 119(18):2843-2857. PubMed ID: 38039351
[TBL] [Abstract][Full Text] [Related]
27. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.
Goldberg IJ
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):700-706. PubMed ID: 29419410
[TBL] [Abstract][Full Text] [Related]
28. Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.
Zhang BH; Yin F; Qiao YN; Guo SD
Front Mol Biosci; 2022; 9():909151. PubMed ID: 35693558
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
Kohan AB
Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):119-25. PubMed ID: 25692924
[TBL] [Abstract][Full Text] [Related]
30. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.
Drager LF; Li J; Shin MK; Reinke C; Aggarwal NR; Jun JC; Bevans-Fonti S; Sztalryd C; O'Byrne SM; Kroupa O; Olivecrona G; Blaner WS; Polotsky VY
Eur Heart J; 2012 Mar; 33(6):783-90. PubMed ID: 21478490
[TBL] [Abstract][Full Text] [Related]
31. Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders.
Demignot S; Beilstein F; Morel E
Biochimie; 2014 Jan; 96():48-55. PubMed ID: 23871915
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein lipase. Mechanism of formation of triglyceride-rich remnant particles from very low density lipoproteins and chylomicrons.
Higgins JM; Fielding CJ
Biochemistry; 1975 Jun; 14(11):2288-93. PubMed ID: 166652
[TBL] [Abstract][Full Text] [Related]
33. Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall.
Öörni K; Lehti S; Sjövall P; Kovanen PT
Curr Med Chem; 2019; 26(9):1701-1710. PubMed ID: 29848270
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of lipoprotein transport.
Brunzell JD; Chait A; Bierman EL
Metabolism; 1978 Sep; 27(9):1109-27. PubMed ID: 210352
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of hypertriglyceridemia.
Hassing HC; Surendran RP; Mooij HL; Stroes ES; Nieuwdorp M; Dallinga-Thie GM
Biochim Biophys Acta; 2012 May; 1821(5):826-32. PubMed ID: 22179026
[TBL] [Abstract][Full Text] [Related]
36. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
37. Roles of lipoprotein lipase and hepatic triglyceride lipase in the catabolism in vivo of triglyceride-rich lipoproteins.
Reardon MF; Sakai H; Steiner G
Arteriosclerosis; 1982; 2(5):396-402. PubMed ID: 7126037
[TBL] [Abstract][Full Text] [Related]
38. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
39. Plasma triglyceride metabolism.
Robinson DS
J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():5-10. PubMed ID: 4354847
[No Abstract] [Full Text] [Related]
40. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
